[Breaking News] For 5 companies and 5 products that are recipients of Kobayashi Pharmaceutical's 'Kouji' shipment, it has been discovered that intake has exceeded the reported amount of health damage. 'Unreported' cases found in the country.

2024/07/26 18:36
On the 26th, Kobayashi Pharmaceutical and the Ministry of Health, Labour and Welfare announced that out of the 225 companies that were recipients of the raw material "red yeast rice", it has been revealed that there have been reports of health damage for 5 products from 5 companies exceeding the daily intake of red yeast rice (100 milligrams).
Until now, except for 3 products such as "Red Yeast Rice CholesteHelp", it was reported that they were not applicable, but it has been revealed that they were overlooked during the investigation.

The following 5 companies have announced the production of 5 products:

① "DHA&EPA" produced by Fuji Capsule Manufacturing (daily intake exceeding 100 milligrams)
② "Shigenryu" produced by PC System (daily intake exceeding 200 milligrams)
③ Products produced by Seiyu Corporation
④ Products produced by Asnaro Chemical Research Institute
⑤Commodity etf manufactured by Japan Health
Among them, there is a possibility that products① Noevir "DHA＆EPA" and② Sankwell "fatty acid reduction flow" were manufactured using lots where the presence of pberull acid was detected.